Consolidated Statements Of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Operating expenses:
Research and development expenses	$ (212)	$ (230)	$ (392)	$ (451)
General and administrative expenses	(938)	(609)	(1,904)	(2,118)
Operating loss	(1,150)	(839)	(2,296)	(2,569)
Financial loss, net	(1,912)	(33)	(4,936)	(8)
Net loss	$ (3,062)	$ (872)	$ (7,232)	$ (2,577)
Basic and diluted net loss per share	$ (0.19)	$ (0.08)	$ (0.44)	$ (0.26)
Weighted average number of shares of common stock used in computing basic and diluted net loss per share	16,296,791	10,806,155	16,149,313	10,101,073